vimarsana.com

Novartis Kesimpta News Today : Breaking News, Live Updates & Top Stories | Vimarsana

China 2022 National Reimbursement Drug List Drug Pricing

China National Healthcare Security Administration NHSA published 2022 National Reimbursement Drug List 2022 NRDL, implementing comparable level of pricing discounts to those seen in 2021. Out of 147 drugs negotiated, 121 were successfully added to 2022 NRDL, including 91 exclusive.

Genmab A/S (GMAB) Q2 2022 Earnings Call Transcript

vimarsana © 2020. All Rights Reserved.